全文获取类型
收费全文 | 1162篇 |
免费 | 159篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 8篇 |
妇产科学 | 8篇 |
基础医学 | 24篇 |
口腔科学 | 19篇 |
临床医学 | 319篇 |
内科学 | 467篇 |
皮肤病学 | 8篇 |
神经病学 | 82篇 |
特种医学 | 4篇 |
外科学 | 93篇 |
综合类 | 38篇 |
现状与发展 | 1篇 |
预防医学 | 31篇 |
眼科学 | 5篇 |
药学 | 211篇 |
中国医学 | 1篇 |
肿瘤学 | 18篇 |
出版年
2023年 | 27篇 |
2022年 | 49篇 |
2021年 | 67篇 |
2020年 | 110篇 |
2019年 | 108篇 |
2018年 | 112篇 |
2017年 | 84篇 |
2016年 | 75篇 |
2015年 | 73篇 |
2014年 | 89篇 |
2013年 | 124篇 |
2012年 | 35篇 |
2011年 | 37篇 |
2010年 | 24篇 |
2009年 | 30篇 |
2008年 | 24篇 |
2007年 | 29篇 |
2006年 | 25篇 |
2005年 | 24篇 |
2004年 | 17篇 |
2003年 | 28篇 |
2002年 | 13篇 |
2001年 | 12篇 |
2000年 | 11篇 |
1999年 | 5篇 |
1998年 | 8篇 |
1997年 | 5篇 |
1996年 | 7篇 |
1995年 | 9篇 |
1994年 | 5篇 |
1993年 | 9篇 |
1992年 | 3篇 |
1991年 | 8篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 7篇 |
1984年 | 8篇 |
1983年 | 6篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有1341条查询结果,搜索用时 248 毫秒
91.
B. Cosmi 《Journal of thrombosis and haemostasis》2015,13(7):1175-1183
Superficial vein thrombosis (SVT) is less well studied than deep vein thrombosis (DVT), because it has been considered to be a minor, self‐limiting disease that is easily diagnosed on clinical grounds and that requires only symptomatic relief. The most frequently involved sites of the superficial vein system are the lower limbs, especially the saphenous veins, mostly in relation to varicosities. Lower‐limb SVT shares the same risk factors as DVT; it can propagate into the deep veins, and have a complicated course with pulmonary embolism. Clinical diagnosis may not be accurate, and ultrasonography is currently indicated for both confirmation and evaluation of SVT extension. Treatment aims are symptom relief and prevention of venous thromboembolism (VTE) in relation to the thrombotic burden. SVT of the long saphenous vein within 3 cm of the saphenofemoral junction (SFJ) is considered to be equivalent to a DVT, and thus deserving of therapeutic anticoagulation. Less severe forms of lower‐limb SVT not involving the SFJ have been included in randomized clinical trials of surgery, compression hosiery, non‐steroidal anti‐inflammatory drugs, unfractionated heparin, and low molecular weight heparins, with inconclusive results. The largest randomized clinical trial available, on 3004 patients with lower‐limb SVT not involving the SFJ, showed that fondaparinux 2.5 mg once daily for 6 weeks is more effective than placebo in reducing the risk of the composite of death from any cause and symptomatic VTE (0.9% versus 5.9%). Further studies are needed to define the optimal management strategies for SVT of the lower limbs and other sites, such as the upper limbs. 相似文献
92.
93.
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings 下载免费PDF全文
94.
95.
The increasing incidence of thrombosis in hospitalized patients in the 21st century is due to improved awareness by clinicians and more sophisticated forms of imaging. Thromboprophylaxis is now an imperative in the NHS of the UK and this combined with new, improved and safer forms of anticoagulation means that postoperative deaths from venous thromboembolic disease should become a thing of the past. In the following paper the authors review the up-to-date literature with emphasis on the newer anticoagulants that do not require blood test monitoring. We fully accept that this is a developing field and that the recognized indications for certain of these agents will change with the accumulation of further evidence. 相似文献
96.
97.
《Journal of the American College of Cardiology》2019,73(24):3135-3147
The burden of cardiovascular (CV) disease is very high in China, due to highly prevalent and poorly controlled risk factors resulting from changing sociodemographic structure and lifestyles in its large population. Rapid economic development and urbanization have been accompanied by changing patterns, expression, and management of CV disease. However, the health care system in China lacks a hierarchical structure, with a focus on treating acute diseases in hospital while ignoring long-term management, and primary health care is too weak to effectively control CV risk factors. To address these challenges, the Chinese central government has ensured health is a national priority and has introduced reforms that include implementing policies for a healthy environment, strengthening primary care, and improving affordability and accessibility within the health system. Turning the inverted pyramid of the health care system is essential in the ongoing battle against CV disease. 相似文献
98.
Robert B. Howard 《Postgraduate medicine》2013,125(2):27-28
Readers are invited to submit questions relating to problem cases. Inquiries will be answered by qualified consultants and replies forwarded by mail promptly. Selected problems and solutions are published every month in this section. 相似文献
99.
100.